Piperacillin & Tazobactam Injection

Injections · Powder for Injection · 4.5g (4g + 0.5g), 2.25g (2g + 0.25g)

Trade Information

Minimum Order Qty	500,000 vials
Capacity	50 Million Vials per month
Strength	4.5g (4g + 0.5g), 2.25g (2g + 0.25g)
Private Labelling	Custom branding, artwork & market-specific labelling
Lead Time	45–60 days from order confirmation
Payment Terms	LC at sight, TT (advance / against documents)
Shipping	FOB / CIF to major international ports including Mombasa, Dar es Salaam, Lagos, Durban, Manila, Phnom Penh
Pharmacopoeia	BP, USP, IP compliant

Packing Options

Single vial pack
Tray pack
Hospital bulk pack
Custom packing as per buyer requirement

Regulatory & Quality

Registration Status	Dossier available for new market registration.
Regulatory Dossiers	CTD / ACTD format dossiers available for submission to national drug authorities.
Stability Data	Zone IVa & IVb stability data available (tropical climate conditions, 30°C/65% RH & 30°C/75% RH)
WHO Prequalification	WHO-GMP Certified

Product Details

Composition	Piperacillin + Tazobactam
Dosage Form	Powder for Injection
Pack Size	Vial / Tray pack / Custom packing available
Storage	Store below 25°C in a dry place, protected from light
Shelf Life	24 months from date of manufacture

Description

Piperacillin-Tazobactam is a broad-spectrum penicillin combined with a beta-lactamase inhibitor, widely used in hospitals for serious bacterial infections. It is a mainstay of hospital empirical therapy and is listed on the WHO Model List of Essential Medicines.

BioGalen manufactures Piperacillin-Tazobactam injection in 4.5g and 2.25g presentations, supplied through hospital and tender channels for serious infections including sepsis and hospital-acquired pneumonia.

Mechanism of Action

Piperacillin-Tazobactam combines piperacillin, a broad-spectrum penicillin that inhibits bacterial cell wall synthesis, with tazobactam, a beta-lactamase inhibitor. Many serious hospital pathogens produce beta-lactamase enzymes that would otherwise inactivate piperacillin. Tazobactam protects piperacillin, restoring and broadening its activity, including against many Gram-negative organisms and anaerobes. The combination is a mainstay of hospital empirical therapy for serious infections.

Indications

Sepsis and bloodstream infections
Hospital-acquired and ventilator-associated pneumonia
Complicated intra-abdominal infections
Complicated skin and soft tissue infections
Febrile neutropenia (empirical therapy)

Available Variants

Piperacillin 4g & Tazobactam 0.5g Injection (4.5g)
Piperacillin 2g & Tazobactam 0.25g Injection (2.25g)

Frequently Asked Questions

What is Piperacillin-Tazobactam used for?

Piperacillin-Tazobactam is a broad-spectrum penicillin with a beta-lactamase inhibitor, used in hospitals for serious infections including sepsis, hospital-acquired pneumonia, complicated intra-abdominal infections, and febrile neutropenia, often as a broad option before escalation to carbapenems.

What presentations does BioGalen manufacture?

BioGalen manufactures Piperacillin-Tazobactam injection in 4.5 g and 2.25 g presentations as powder for reconstitution, under WHO-GMP with CTD and ACTD dossiers available.

Does BioGalen supply Piperacillin-Tazobactam for tenders?

Yes. BioGalen supplies WHO-GMP Piperacillin-Tazobactam to hospitals, tender suppliers, and national procurement programmes requiring broad-spectrum injectable antibiotics.

Explore More

Interested in Piperacillin & Tazobactam Injection?

Get competitive pricing for bulk orders, private labelling, and contract manufacturing.

WhatsApp Enquiry Contact Us

Browse Categories

Browse by Dosage Form